Good morning :)
$
₹
A

Alamar Biosciences, Inc. Common Stock

ALMR

NASDAQ
A

Alamar Biosciences, Inc. Common Stock

ALMR

NASDAQ
$33.354.83% (-1.69)
$
₹
$33.354.83% (-1.69)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
Loading...
1D
1W
1M
1Y
5Y
Max

Healthcare

Medical Devices

Mid Cap

With a market cap of $2.4B the stock is ranked 2047

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

—
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

7.72
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$-0.71
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

—
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

-49.45%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

—

Company Profile

Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers. It offers ARGO high throughput (HT) System, a fully automated precision proteomics platform, performs ultra-high sensitivity and multiplexed analysis to support biomarker analysis across the continuum of discovery, translational research and ultimately, and diagnostics. The company's offering is utilized in research areas including immunology, neurology, and oncology. It serves global research and academic institutions, biopharmaceutical companies, contract research organizations, and service labs. The company operates in the United States, rest of Europe, Middle East and Africa, Germany, Asia Pacific, and internationally. It has a strategic partnership with Alzheimer's Disease Data Initiative, and Gates Ventures to advance translational research in alzheimer's disease. The company was incorporated in 2018 and is based in Fremont, California.
Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers. It offers ARGO high throughput (HT) System, a fully automated precision proteomics platform, performs ultra-high sensitivity and multiplexed analysis to support biomarker analysis across the continuum of discovery, translational research and ultimately, and diagnostics. The company's offering is utilized in research areas including immunology, neurology, and oncology. It serves global research and academic institutions, biopharmaceutical companies, contract research organizations, and service labs. The company operates in the United States, rest of Europe, Middle East and Africa, Germany, Asia Pacific, and internationally. It has a strategic partnership with Alzheimer's Disease Data Initiative, and Gates Ventures to advance translational research in alzheimer's disease. The company was incorporated in 2018 and is based in Fremont, California.

Peers

Peers

Abbott Laboratories
ABT
Abbott Laboratories
P/E Ratio
33.20
33.20
1Y Return
24.28%
24.28%
Buy Reco %
74.07
74.07
Danaher Corporation
DHR
Danaher Corporation
P/E Ratio
37.75
37.75
1Y Return
13.52%
13.52%
Buy Reco %
88.00
88.00
Intuitive Surgical Inc
ISRG
Intuitive Surgical Inc
P/E Ratio
45.05
45.05
1Y Return
9.65%
9.65%
Buy Reco %
66.66
66.66
Medtronic PLC
MDT
Medtronic PLC
P/E Ratio
22.69
22.69
1Y Return
3.34%
3.34%
Buy Reco %
53.12
53.12
Stryker Corporation
SYK
Stryker Corporation
P/E Ratio
28.48
28.48
1Y Return
27.1%
27.1%
Buy Reco %
68.75
68.75

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareMedical Devices

Valuation

Returns

Forecast

StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Alamar Biosciences, Inc. Common Stock -7.72-
Abbott Laboratories33.203.471.88
Danaher Corporation37.752.831.26

Price Comparison

Price Comparison

1 Month

1 Year

5 Years

Loading...

Financials

Financials

Income

Balance Sheet

Cash Flow

13
-7.6
16.1
-7
26
-21.3
29.4
-13.1
Q1 2025
Q2 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2025Q2 2025Q1 2026Q2 2026
Total Revenue13.0916.1626.0329.42
Net Income-7.65-7.02-21.32-13.19
Net Profit Margin-58.50%-43.45%-81.90%-44.85%
See CostsAll values in $ Million

Frequently asked questions

  1. Alamar Biosciences, Inc. Common Stock (ALMR) share price today is $33.35 as of September 23, 2026 at 1:30 AM IST. The stock touched a day high of $35.53 and a day low of $32.60.

  2. Alamar Biosciences, Inc. Common Stock stock trades on NASDAQ under the ticker symbol ALMR.

  3. Alamar Biosciences, Inc. Common Stock's market capitalization is $2.41B as of September 23, 2026 at 1:30 AM IST.

  4. Alamar Biosciences, Inc. Common Stock's price-to-earnings (P/E) ratio is N/A as of September 22, 2026.

  5. Alamar Biosciences, Inc. Common Stock's price-to-book (P/B) ratio is 7.72 as of September 22, 2026.

  6. Yes, You can buy Alamar Biosciences, Inc. Common Stock shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy Alamar Biosciences, Inc. Common Stock shares in three steps: 1. Search Alamar Biosciences, Inc. Common Stock on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since Alamar Biosciences, Inc. Common Stock trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in Alamar Biosciences, Inc. Common Stock (ALMR) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.2998 shares at the current price of $33.35.

Loading...